SUPPLEMENTARY INFORMATION:

Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address one or more of the following four points:

—Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the Bureau of Justice Statistics, including whether the information will have practical utility;

—Evaluate the accuracy of the agency's estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used;

—Evaluate whether and if so how the quality, utility, and clarity of the information to be collected can be enhanced; and

—Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses.

Abstract: In accordance with the Controlled Substances Act (CSA), every DEA registrant must make a biennial inventory and maintain, on a current basis, a complete and accurate record of each controlled substance manufactured, received, sold, delivered, or otherwise disposed of. 21 U.S.C. 827 and 958. The records maintained by registrants must be kept and be available for at least two years for inspection and copying by officers or employees of the United States as authorized by the Attorney General. 21 U.S.C. 827(b)(3). Pharmacists are required to maintain a record with the date of each dispensing, the name or initials of the individual who dispensed the substance, and all other information required by 1306.22(c) for schedule III and IV prescription refills. For electronic prescriptions, pharmacy applications need to allow required information pertaining to the quantity, date, and the dispenser to be linked to each electronic controlled substance prescription record

Overview of This Information Collection

1. Type of Information Collection: Extension of a previously approved collection.

2. The Title of the Form/Collection: Recordkeeping Requirements for Partial Fills of Prescriptions for Schedule II Controlled Substances.

3. The agency form number, if any, and the applicable component of the Department sponsoring the collection: No form number is associated with this collection. The applicable component within the Department of Justice is the Drug Enforcement Administration, Diversion Control Division.

4. Affected public who will be asked or required to respond, as well as the obligation to respond: Affected Public: (Primary) Business or other for-profit.

5. An estimate of the total number of respondents and the amount of time estimated for an average respondent to respond: The DEA estimates that 66,088 registrants participate in this information collection. The time per response is less than a minute for to complete the recordkeeping.

6. An estimate of the total annual burden (in hours) associated with the collection: DEA estimates that this collection takes 27,149 annual burden hours.

7. An estimate of the total annual cost burden associated with the collection, if applicable: $0. ( printed page 46486)

If additional information is required contact: Darwin Arceo, Department Clearance Officer, United States Department of Justice, Justice Management Division, Enterprise Portfolio Management, Two Constitution Square, 145 N Street NE, 4W-218, Washington, DC 20530.

91 FR 46485